Adverum reports positive 52-week, 4-year data for wet AMD gene therapy
by: Alex Young & Anthony DeFino Adverum Biotechnologies reported positive 52-week data from the phase 2 LUNA trial as well as long-term follow-up results from the OPTIC trial of Ixo-vec…